
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT
- About
Flora Growth Corp (FLGC)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/11/2025: FLGC (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -95.36% | Avg. Invested days 23 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 11.66M USD | Price to earnings Ratio - | 1Y Target Price 4 |
Price to earnings Ratio - | 1Y Target Price 4 | ||
Volume (30-day avg) 254475 | Beta 1.99 | 52 Weeks Range 0.53 - 2.59 | Updated Date 04/2/2025 |
52 Weeks Range 0.53 - 2.59 | Updated Date 04/2/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.3 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-03-25 | When - | Estimate -0.11 | Actual -0.4247 |
Profitability
Profit Margin -26.73% | Operating Margin (TTM) -38.75% |
Management Effectiveness
Return on Assets (TTM) -33.12% | Return on Equity (TTM) -291.5% |
Valuation
Trailing PE - | Forward PE 7.89 | Enterprise Value 10542441 | Price to Sales(TTM) 0.2 |
Enterprise Value 10542441 | Price to Sales(TTM) 0.2 | ||
Enterprise Value to Revenue 0.18 | Enterprise Value to EBITDA -1 | Shares Outstanding 19435600 | Shares Floating 15303100 |
Shares Outstanding 19435600 | Shares Floating 15303100 | ||
Percent Insiders 32.91 | Percent Institutions 7.6 |
Analyst Ratings
Rating 4 | Target Price 4 | Buy 1 | Strong Buy 1 |
Buy 1 | Strong Buy 1 | ||
Hold 1 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Flora Growth Corp
Company Overview
History and Background
Flora Growth Corp. was founded in 2019 and is a vertically integrated cannabis company. It focuses on producing cannabis-derived products, leveraging low-cost cultivation in Colombia and distribution in international markets.
Core Business Areas
- Flora Beauty: Cosmetics and skincare products infused with cannabis-derived ingredients.
- Flora Pharma: Medical cannabis products and pharmaceuticals.
- Commercial Wholesale: Sells bulk cannabis and derivatives to other companies.
- Food and Beverage: Cannabis-infused foods and beverages.
Leadership and Structure
Luis Merchan is the Chairman and CEO. The company has a board of directors and various management teams responsible for different business segments. The structure focuses on vertical integration and international expansion.
Top Products and Market Share
Key Offerings
- Mindy Kaling x Costa Brazil Collection: A collaborative line of skincare products infused with natural ingredients. Market share is difficult to ascertain given the limited availability of information. Competitors: Sephora brands, other celebrity skincare collaborations.
- JustCBD Brand: A line of CBD products including edibles, topicals, and oils. Competition is fierce in the CBD market, with many players like Charlotte's Web, CBDMD and other major brands, Flora Growth share for this is difficult to pinpoint.
Market Dynamics
Industry Overview
The global cannabis market is experiencing rapid growth, driven by increasing legalization and consumer acceptance. It comprises recreational and medicinal cannabis, CBD products, and related services.
Positioning
Flora Growth aims to be a low-cost producer and distributor, leveraging its cultivation operations in Colombia to supply international markets. They have positioned themselves in beauty, pharma, wholesale, and food and beverage to capture the cannabis market
Total Addressable Market (TAM)
The global cannabis market is projected to reach hundreds of billions of dollars by the end of the decade. Flora Growth's positioning allows them to address various segments within this expansive TAM.
Upturn SWOT Analysis
Strengths
- Low-cost cultivation in Colombia
- Vertically integrated operations
- Diversified product portfolio
- International distribution network
Weaknesses
- Limited brand recognition
- Dependence on regulatory changes
- Negative profitability
- High operational and capital expenditures
Opportunities
- Expansion into new international markets
- Increased demand for cannabis-derived products
- Strategic acquisitions
- Product Innovation
Threats
- Fluctuations in cannabis prices
- Intense competition
- Changing regulations
- Economic downturns
Competitors and Market Share
Key Competitors
- CGC
- TLRY
- ACB
Competitive Landscape
Flora Growth's low-cost production could be a competitive advantage, but it faces significant competition from established players with greater brand recognition and market share. Note market share data is difficult to accurately determine given varying definitions of the overall cannabis market and the companies' specific segments of focus.
Major Acquisitions
Just Brands LLC
- Year: 2022
- Acquisition Price (USD millions): 30
- Strategic Rationale: Expanded the company's footprint in the US CBD market through the addition of this established brand. The goal was to accelerate revenue growth and market penetration for its consumer brand division.
Growth Trajectory and Initiatives
Historical Growth: Past growth has been driven by acquisitions and expansion into new markets. However, profitability remains a challenge.
Future Projections: Future growth relies on increased sales and successful integration of acquired assets. Analyst expectations will be needed to be analyzed.
Recent Initiatives: Recent initiatives include expanding product lines and entering new distribution partnerships.
Summary
Flora Growth is trying to establish itself within the booming cannabis market by focusing on low-cost cultivation and global distribution. However, it faces challenges with profitability, fierce competition, and the need for a stronger brand presence. Successful integration of acquired assets and scaling up operations will be critical. Investors should closely monitor regulatory changes and market conditions to assess the company's long-term viability.
Similar Companies

ACB

Aurora Cannabis Inc



ACB

Aurora Cannabis Inc

CGC

Canopy Growth Corp



CGC

Canopy Growth Corp

CRON

Cronos Group Inc



CRON

Cronos Group Inc

TLRY

Tilray Inc



TLRY

Tilray Inc
Sources and Disclaimers
Data Sources:
- Company filings
- Industry reports
- Financial news sources
Disclaimers:
This analysis is based on publicly available information and does not constitute investment advice. Market conditions and company performance can change rapidly.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Flora Growth Corp
Exchange NASDAQ | Headquaters Fort Lauderdale, FL, United States | ||
IPO Launch date 2021-05-11 | CEO & Director Mr. Clifford A. Starke | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 64 | Website https://www.floragrowth.com |
Full time employees 64 | Website https://www.floragrowth.com |
Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products. It also offers food and beverage, nutraceuticals, cannabis accessories and technology, personal care, and wellness; cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; cannabis consumption accessories, personal storage, and travel accessories for the vape and dry herbs. In addition, the company manufactures and distributes pharmaceutical goods and medical cannabis products to treat a variety of health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. The company sells its products under the JustCBD, Vessel, and Phatebo brands. Flora Growth Corp. was incorporated in 2019 and is based in Fort Lauderdale, Florida.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.